A Phase 1, Open-Label, Multicenter Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer

[No_stone_unturned]

I have a choice between this trial and a BAT trial. I’m already preferential to BAT, but without being too hasty, I wanted to see if anyone here has any experience with JANX00x before deciding.

[GP24]

The immunotherapy trial will cause more side effects than the BAT trial. I would choose BAT now and maybe take part in the phase II trial of JANX007 when that has begun.

[No_stone_unturned in reply to GP24]

I like your logic. Ty.

[Tall_Allen]

The BiTE trial can extend survival if it works. There is no indication that a BAT trial can extend survival, but it may improve QOL. They are both risky.

[j-o-h-n]

Well at least your true to your UserID...... Keep turning ahead!!!

Good Luck, Good Health and Good Humor.

j-o-h-n